View in EDS HTML Full Text PDF Full Text

Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.

Saved in:
Bibliographic Details
Title: Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
Authors: Sulkowski M; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Telep LE; Gilead Sciences, Inc., Foster City, California, USA., Colombo M; M Colombo Liver Center, San Raffaele Hospital, Milan, Italy., Durand F; Hôpital Beaujon, University Paris Diderot, Clichy, France., Reddy KR; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Lawitz E; Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, USA., Bourlière M; Hépato-Gastro-Entérologie, Hôpital Saint Joseph, Marseille, France.; INSERM 1252, IRD, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Aix-Marseille University, Marseille, France., Cheinquer N; Gilead Sciences, Inc., Foster City, California, USA., Scherbakovsky S; Gilead Sciences, Inc., Foster City, California, USA., Ni L; Gilead Sciences, Inc., Foster City, California, USA., Force L; Gilead Sciences, Inc., Foster City, California, USA., Ramroth H; Gilead Sciences, Inc., Foster City, California, USA., Gaggar A; Gilead Sciences, Inc., Foster City, California, USA., Chokkalingam AP; Gilead Sciences, Inc., Foster City, California, USA., Sise ME; Massachusetts General Hospital, Boston, Massachusetts, USA.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 May; Vol. 55 (9), pp. 1169-1178. Date of Electronic Publication: 2022 Mar 02.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35235245
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sulkowski+M%22">Sulkowski M</searchLink>; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Telep+LE%22">Telep LE</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Colombo+M%22">Colombo M</searchLink>; M Colombo Liver Center, San Raffaele Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Durand+F%22">Durand F</searchLink>; Hôpital Beaujon, University Paris Diderot, Clichy, France.<br /><searchLink fieldCode="AU" term="%22Reddy+KR%22">Reddy KR</searchLink>; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Lawitz+E%22">Lawitz E</searchLink>; Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bourlière+M%22">Bourlière M</searchLink>; Hépato-Gastro-Entérologie, Hôpital Saint Joseph, Marseille, France.; INSERM 1252, IRD, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Cheinquer+N%22">Cheinquer N</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Scherbakovsky+S%22">Scherbakovsky S</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Ni+L%22">Ni L</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Force+L%22">Force L</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Ramroth+H%22">Ramroth H</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Gaggar+A%22">Gaggar A</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Chokkalingam+AP%22">Chokkalingam AP</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Sise+ME%22">Sise ME</searchLink>; Massachusetts General Hospital, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2022 May; Vol. 55 (9), pp. 1169-1178. <i>Date of Electronic Publication: </i>2022 Mar 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2036 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35235245
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/apt.16830
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1169
    Titles:
      – TitleFull: Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sulkowski M
      – PersonEntity:
          Name:
            NameFull: Telep LE
      – PersonEntity:
          Name:
            NameFull: Colombo M
      – PersonEntity:
          Name:
            NameFull: Durand F
      – PersonEntity:
          Name:
            NameFull: Reddy KR
      – PersonEntity:
          Name:
            NameFull: Lawitz E
      – PersonEntity:
          Name:
            NameFull: Bourlière M
      – PersonEntity:
          Name:
            NameFull: Cheinquer N
      – PersonEntity:
          Name:
            NameFull: Scherbakovsky S
      – PersonEntity:
          Name:
            NameFull: Ni L
      – PersonEntity:
          Name:
            NameFull: Force L
      – PersonEntity:
          Name:
            NameFull: Ramroth H
      – PersonEntity:
          Name:
            NameFull: Gaggar A
      – PersonEntity:
          Name:
            NameFull: Chokkalingam AP
      – PersonEntity:
          Name:
            NameFull: Sise ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2036
          Numbering:
            – Type: volume
              Value: 55
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Alimentary pharmacology & therapeutics
              Type: main
ResultId 1